Mystery caller study on emergency contraception in Germany!

By João L. Carapinha

June 20, 2023

Researchers examined immediate availability, pricing, and counseling aspects of oral emergency contraception in Berlin pharmacies.
Results included:

✅ Ulipristal acetate prices ranged from €15.95 to €42.95 (median €35.00)
✅ Levonorgestrel prices ranged from €10.60 to €32.49 (median €22.00)

Great access, but high price ranges pose challenges. A comparison app could help minimize costs. Pharmacy staff training is essential for providing “adequate” counseling.

Reference url

Recent Posts

UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient Access and Market G...

By Staff Writer

August 25, 2025

The accelerated review of the UK's Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) concluded without agreement in August 2025. The review focused on soaring payment rates. These require companies to pay up to 35.6% of their revenue from NHS sales. Despite good faith effo...
Key Decisions on Health Technology Assessment at ACP124: Implications for Rare Disease Therapies

By João L. Carapinha

August 19, 2025

Health technology assessment (HTA) plays a crucial role in determining whether new therapies are reimbursed within healthcare systems. At the July 18, 2025 meeting of the Adviescommissie Pakket (ACP), two high-profile orphan drugs—omaveloxolone (Skyclarys®) for Friedreich’s ataxia and exagamgloge...
Eli Lilly’s Innovation Statement: Advocating Drug Pricing Reforms

By Staff Writer

August 18, 2025

Eli Lilly has issued a statement advocating for US drug pricing reforms. It emphasizes maintaining America's leadership in biopharmaceutical innovation. The Eli Lilly innovation statement highlights a $50 billion US manufacturing investment since 2020. This includes four new sites and opposes tar...